These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8429231)

  • 1. Effects of adequate versus inadequate treatment of cutaneous manifestations of Lyme borreliosis on the incidence of late complications and late serologic status.
    Plörer A; Sepp N; Schmutzhard E; Krabichler S; Trobos S; Schauer G; Pahl C; Stöffler G; Fritsch P
    J Invest Dermatol; 1993 Feb; 100(2):103-9. PubMed ID: 8429231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant immunoblot in the serodiagnosis of Lyme borreliosis. Comparison with indirect immunofluorescence and enzyme-linked immunosorbent assay.
    Wilske B; Fingerle V; Herzer P; Hofmann A; Lehnert G; Peters H; Pfister HW; Preac-Mursic V; Soutschek E; Weber K
    Med Microbiol Immunol; 1993 Nov; 182(5):255-70. PubMed ID: 8283961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphoproliferative responses to Borrelia burgdorferi in patients with erythema migrans, acrodermatitis chronica atrophicans, lymphadenosis benigna cutis, and morphea.
    Buechner SA; Lautenschlager S; Itin P; Bircher A; Erb P
    Arch Dermatol; 1995 Jun; 131(6):673-7. PubMed ID: 7778918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skin manifestations of lyme borreliosis: diagnosis and management.
    Müllegger RR; Glatz M
    Am J Clin Dermatol; 2008; 9(6):355-68. PubMed ID: 18973402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serodiagnosis of erythema migrans and acrodermatitis chronica atrophicans by the Borrelia burgdorferi flagellum enzyme-linked immunosorbent assay.
    Hansen K; Asbrink E
    J Clin Microbiol; 1989 Mar; 27(3):545-51. PubMed ID: 2715325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous manifestations of Lyme borreliosis.
    Aberer E; Klade H
    Infection; 1991; 19(4):284-6. PubMed ID: 1917047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Livedo racemosa: an unusual late manifestation of borreliosis?].
    Baumann M; Tebbe B; Arnold M; Krengel S; Goerdt S; Orfanos CE
    Hautarzt; 2000 Aug; 51(8):593-6. PubMed ID: 10997315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotic therapy of early European Lyme borreliosis and acrodermatitis chronica atrophicans.
    Weber K; Preac-Mursic V; Neubert U; Thurmayr R; Herzer P; Wilske B; Schierz G; Marget W
    Ann N Y Acad Sci; 1988; 539():324-45. PubMed ID: 3056202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythema migrans and serodiagnosis by enzyme immunoassay and immunoblot with three borrelia species.
    Stanek G; Breier F; Menzinger G; Schaar B; Hafner M; Partsch H
    Wien Klin Wochenschr; 1999 Dec; 111(22-23):951-6. PubMed ID: 10666807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is serological follow-up useful for patients with cutaneous Lyme borreliosis?
    Müllegger RR; Glatz M
    Curr Probl Dermatol; 2009; 37():178-182. PubMed ID: 19367102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enzyme-linked immunosorbent assay, immunofluorescent assay, and recombinant immunoblotting in the serodiagnosis of early Lyme borreliosis.
    Christova I
    Int J Immunopathol Pharmacol; 2003; 16(3):261-8. PubMed ID: 14611730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serologic studies of erythema chronicum migrans Afzelius and acrodermatitis chronica atrophicans with indirect immunofluorescence and enzyme-linked immunosorbent assays.
    Asbrink E; Hovmark A; Hederstedt B
    Acta Derm Venereol; 1985; 65(6):509-14. PubMed ID: 2420115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The outcome of Lyme borreliosis in children.
    Aberer E; Kehldorfer M; Binder B; Schauperi H
    Wien Klin Wochenschr; 1999 Dec; 111(22-23):941-4. PubMed ID: 10666805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cutaneous manifestations of Lyme disease : Pitfalls in the serological diagnostic workup].
    Glatz M; Müllegger RR
    Hautarzt; 2017 Apr; 68(4):329-339. PubMed ID: 28236088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lyme borreliosis. Cutaneous manifestation].
    Hofmann H
    Hautarzt; 2005 Aug; 56(8):783-95; quiz 796. PubMed ID: 16025277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous Lyme borreliosis: Guideline of the German Dermatology Society.
    Hofmann H; Fingerle V; Hunfeld KP; Huppertz HI; Krause A; Rauer S; Ruf B;
    Ger Med Sci; 2017; 15():Doc14. PubMed ID: 28943834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serodiagnosis of Lyme borreliosis using detection of different immunoglobulin (sub)classes by enzyme-linked immunosorbent assay and Western blotting.
    Goossens HA; van den Bogaard AE; Nohlmans MK
    Clin Lab; 2001; 47(1-2):41-9. PubMed ID: 11214222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dermatological manifestations of Lyme borreliosis.
    Mullegger RR
    Eur J Dermatol; 2004; 14(5):296-309. PubMed ID: 15358567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genotyping of Borrelia from formalin-fixed paraffin-embedded skin biopsies of cutaneous borreliosis and tick bite reactions by assays targeting the intergenic spacer region, ospA and ospC genes.
    Brandt FC; Ertas B; Falk TM; Metze D; Böer-Auer A
    Br J Dermatol; 2014 Sep; 171(3):528-43. PubMed ID: 24471698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serological follow-up after treatment of Borrelia arthritis and acrodermatitis chronica atrophicans.
    Hammers-Berggren S; Lebech AM; Karlsson M; Andersson U; Hansen K; Stiernstedt G
    Scand J Infect Dis; 1994; 26(3):339-47. PubMed ID: 7939435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.